Massive anti-depressant usage is brought on by rising anxiety and depression rates, which is helping the expansion of the world phenylalanine market. For instance, the World Health Organisation (WHO) statistics findings show that in 2017, over 300 million individuals worldwide of all ages suffered from depression, and that the primary causes of 800,000 suicide deaths globally were depression and anxiety disorders. Additionally, during the course of the forecast period, the market for phenylalanine is anticipated to rise because to the high frequency of chronic pain conditions. For instance, 1.8 billion people worldwide experienced chronic pain in 2011, according to the American Academy of Pain Medicine (AAPM). The market for phenylalanine is also expanding due to the rising prevalence of chronic illnesses including cancer and pain. For instance, the National Cancer Institute predicts that in 2018, there will be around 1,735,350 new cases of cancer identified in the U.S. and 609,640 cancer-related deaths.
According to Coherent Market Insights, The market for Phenylalanine is anticipated to be worth USD 886.9 million in 2022 and reach USD 990.6 million by 2028 after being readjusted, with a CAGR of 1.9% over the study period.
Leading Companies in the Phenylalanine Industry:
LiftMode (Synaptent LLC)
The company was founded in 2010 and has its main office in Chicago, Illinois, United States. The business is committed to offering top-notch mental and physical health. Liftmode gives customers the greatest deal on genuine Supplements and Nootropics at reasonable prices and in practical dosages.
NutraMarks, Inc
The firm was founded in 1993 and has its headquarters in united strates. The production, fabrication, or processing of medications in pharmaceutical formulations for human or veterinary use is a part of the company's activity. One of the biggest producers of nutritional supplements, personal care products, and healthy meals available in health and natural food stores in the country is NutraMarks.